Managing Emerging Infectious Diseases: Should Travel Be the Fifth Vital Sign?
- PMID: 32120386
- PMCID: PMC7081174
- DOI: 10.7326/M20-0643
Managing Emerging Infectious Diseases: Should Travel Be the Fifth Vital Sign?
Abstract
In the setting of emerging infections, such as COVID-19, this commentary argues that all members of the health care team need training on how to integrate key epidemiologic information, such as travel history, into their risk assessments in the same way they are trained to ask about tobacco exposure to assess cancer and heart disease risk.
References
-
- Errett NA, Sauer LM, Rutkow L. An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure. J Emerg Manag. 2020;18:7-14. [PMID: 32031668] doi:10.5055/jem.2020.0446. - PubMed
-
- Read JM, Bridgen JRE, Cummings DAT, et al. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic prediction. Preprint. Posted online 24 January 2020. medRxiv 20018549. doi:10.1101/2020.01.23.20018549.
-
- Chinazzi M, Davis JT, Ajelli M, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak. Preprint. Posted online 11 February 2020. medRxiv 20021261. doi:10.1101/2020.02.09.20021261.
MeSH terms
LinkOut - more resources
Full Text Sources